Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0000950170-25-085475

Options or other derivatives

  • Director acquired 65,141 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Miller-Rich Nancy Director 2025-06-10 Grant or award · Stock Option (Right to Buy) +62,728 62,728 D
Miller-Rich Nancy Director 2025-06-10 Grant or award · Stock Option (Right to Buy) +2,413 2,413 D
Loading xslF345X05/ownership.xml…